Blood Coagulation Tests Concept

subject area of

• 10 Anticoagulant therapy in venous thromboembolism  Journal Articles
• 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Journal Articles
• A Comparison of Lyophilized Artificially Depleted Plasmas and Lyophilized Plasmas From Patients Receiving Warfarin in Correcting for Coagulometer Effects on International Normalized Ratios  Journal Articles
• A New Short Infusion Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Venous Thromboembolic Disease  Journal Articles
• A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time  Journal Articles
• A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran  Journal Articles
• A cohort study of coagulation parameters and the use of blood products in surgery of the thoracic and thoracoabdominal aorta  Journal Articles
• A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin–antithrombin complex, D‐dimer and fibrinogen/fibrin fragment E antigen  Journal Articles
• A complete deletion of the factor IX gene and new TaqI variant in a hemophilia B kindred  Journal Articles
• A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism  Journal Articles
• A personalized limited sampling approach to better estimate terminal half‐life of FVIII concentrates  Journal Articles
• A prospective study investigating the mechanism of thrombocytopenia in preeclampsia.  Journal Articles
• A specific fluorescence resonance energy quenching–based biosensor for measuring thrombin activity in whole blood  Journal Articles
• Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy  Journal Articles
• Activated protein C resistance, factor V Leiden and peripheral vascular disease.  Journal Articles
• Acute management of bleeding in patients on novel oral anticoagulants  Journal Articles
• An Assessment of the State of Current Practice in Coagulation Laboratories  Journal Articles
• Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls  Journal Articles
• Anticoagulants in Venous Thromboembolism  Journal Articles
• Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism  Journal Articles
• Antithrombin III‐Amiens: A new family with an Arg⁴⁷ → cys inherited variant of antithrombin iii with impaired heparin cofactor activity  Journal Articles
• Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Approaches to the measurement of the response to Factor VIII concentrate infusion  Journal Articles
• Are laboratories following published recommendations for lupus anticoagulant testing?  Journal Articles
• Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia  Journal Articles
• Assays for Measuring Rivaroxaban: Their Suitability and Limitations  Journal Articles
• Assembly and evaluation of an inventory of guidelines that are available to support clinical hematology laboratory practice  Journal Articles
• Blood tests for the diagnosis of venous and arterial thrombosis  Journal Articles
• Capillary Whole Blood Monitoring of Oral Anticoagulants in Children in Outpatient Clinics and the Home Setting  Journal Articles
• Carrier detection strategy in haemophilia A: the benefits of combined DNA marker analysis and coagulation testing in sporadic haemophilic families  Journal Articles
• Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits  Journal Articles
• Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity  Journal Articles
• Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes  Conferences
• Circulating heparin‐like anticoagulants: Case report and review of literature  Journal Articles
• Coagulation Assays  Journal Articles
• Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure  Journal Articles
• Combined administration of barbourin–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta  Journal Articles
• Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist  Journal Articles
• Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease  Journal Articles
• Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis  Journal Articles
• Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations  Journal Articles
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Journal Articles
• Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.  Journal Articles
• Congenital afibrinogenaemia.  Journal Articles
• Critical Values in the Coagulation Laboratory Results of a Survey of the North American Specialized Coagulation Laboratory Association  Journal Articles
• Dabigatran monitoring made simple?  Journal Articles
• Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran  Journal Articles
• Development of the human coagulation system in the full-term infant  Journal Articles
• Developmental haemostasis  Journal Articles
• Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation  Journal Articles
• Diagnosis of thrombosis. Evaluation of 125I-fibrinogen scanning and blood tests.  Journal Articles
• Diagnostic Assessment of Platelet Disorders: What Are the Challenges to Standardization?  Journal Articles
• Diagnostic Evaluation of Platelet Disorders: The Past, the Present, and the Future  Journal Articles
• Diagnostic approach to platelet function disorders  Journal Articles
• Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH  Journal Articles
• Direct Oral Anticoagulants  Journal Articles
• Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa–based methods overestimate antithrombin activity in some patients?  Journal Articles
• Do Coagulation Screening Tests Detect Increased Generation of Thrombin and Plasmin in Sick Newborn Infants?  Journal Articles
• Dosage Regimens for Streptokinase Treatment: Evaluation of a Standard Dosage Schedule  Journal Articles
• Dysfibrinogenaemia and liver cell growth.  Journal Articles
• Dysfibrinogenemia in Obstructive Liver Disease  Journal Articles
• EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE  Journal Articles
• Effect of Streptokinase on Hemostasis  Journal Articles
• Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.  Journal Articles
• Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers  Journal Articles
• Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure  Journal Articles
• Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.  Journal Articles
• Effectiveness of Anticoagulants  Journal Articles
• Elevated Platelet-Associated IgG in the Thrombocytopenia of Septicemia  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.  Journal Articles
• Exploring some intersections between pharmacokinetics, factor VIII measurement and human morphometrics – impact of recent advances in haemophilia study design on our understanding of optimal haemophilia treatment  Journal Articles
• Fetal Effects of Coumadin Administered During Pregnancy  Journal Articles
• Frequency and mechanism of neonatal thrombocytopenia  Journal Articles
• General mechanisms of coagulation and targets of anticoagulants (Section I)  Journal Articles
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation  Journal Articles
• Global haemostasis and point of care testing  Journal Articles
• Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis.  Journal Articles
• HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS  Journal Articles
• Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review  Journal Articles
• Hemostatic System Activation in Patients with Lupus Anticoagulant and Essential Thrombocythemia  Journal Articles
• Heparin Therapy in Venous Thromboembolism  Journal Articles
• Heparin clearance and ex vivo recovery in newborn piglets and adult pigs  Journal Articles
• Heparin kinetics in venous thrombosis and pulmonary embolism.  Journal Articles
• High prevalence of abnormal preoperative coagulation tests in patients with adolescent idiopathic scoliosis  Journal Articles
• Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation  Journal Articles
• Identification of hemostatic markers that define the pre‐DIC state: A multi‐center observational study  Journal Articles
• Immune-mediated thrombocytopenia of malaria.  Journal Articles
• Immunodepletion of human plasma factor VIII  Journal Articles
• Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients  Journal Articles
• Inactivation of thrombin by antithrombin III on a heparinized biomaterial  Journal Articles
• Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082  Journal Articles
• Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta  Journal Articles
• Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys  Journal Articles
• Internal Quality Control Practices in Coagulation Laboratories: recommendations based on a patterns‐of‐practice survey  Journal Articles
• International Committee Communications  Journal Articles
• Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice  Journal Articles
• Laboratory Investigations for Bleeding Disorders  Journal Articles
• Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis  Journal Articles
• Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants  Journal Articles
• Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity  Journal Articles
• Laboratory measurement of the direct oral anticoagulants  Journal Articles
• Laboratory testing for fibrinogen abnormalities  Journal Articles
• Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels  Journal Articles
• Lupus Anticoagulant Testing  Journal Articles
• Management and Monitoring of Anticoagulation for Children Undergoing Cardiopulmonary Bypass in Cardiac Surgery  Journal Articles
• Managing Oral Anticoagulant Therapy  Journal Articles
• Managing oral anticoagulant therapy.  Journal Articles
• Measurement of the Activated Partial Thromboplastin Time from a Capillary (fingerstick) Sample of Whole Blood: A New Method for Monitoring Heparin Therapy  Journal Articles
• Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done?  Journal Articles
• Mechanism of Action and Monitoring of Anticoagulants  Journal Articles
• Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo  Journal Articles
• Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate?  Journal Articles
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Journal Articles
• New Concepts in Coagulation  Journal Articles
• New developments in laboratory diagnosis and monitoring  Journal Articles
• Noninvasive Diagnosis of Deep Venous Thrombosis  Journal Articles
• Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant  Journal Articles
• Performance of recalibrated ReFacto^® laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one‐stage assays after infusion of recalibrated ReFacto^® (B‐domain deleted recombinant factor VIII)  Journal Articles
• Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn  Journal Articles
• Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications  Journal Articles
• Platelet factor 3 availability and the platelet release reaction  Other
• Point-of-Care Hemostatic Testing in Cardiac Surgery  Journal Articles
• Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban  Journal Articles
• Preoperative risk assessment for bleeding and thromboembolism  Journal Articles
• Prevention of Venous Thromboembolism  Journal Articles
• Proceedings: Efficacy and monitoring of heparin therapy in experimental venous thrombosis.  Journal Articles
• Prolonged Prothrombin Time and Partial Thromboplastin Time in Disseminated Intravascular Coagulation not Due to Deficiency of Factors V and VIII  Journal Articles
• Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency: reply to a rebuttal  Journal Articles
• Präoperative Bewertung des Blutungs- und Thromboseembolierisikos  Journal Articles
• Pseudothrombocytopenia Due to Platelet Aggregation and Degranulation in Blood Collected in EDTA  Journal Articles
• RELEVANCE OF PREOPERATIVE AND POSTOPERATIVE BLOOD TESTS TO POSTOPERATIVE LEG-VEIN THROMBOSIS  Journal Articles
• Real‐world variability in dabigatran levels in patients with atrial fibrillation  Journal Articles
• Relation Between Bleeding Time and Platelet Connective Tissue Reaction After Aspirin  Journal Articles
• Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis  Journal Articles
• Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban  Journal Articles
• Resolution of Experimental Pulmonary Emboli with Heparin and Streptokinase in Different Dosage Regimens  Journal Articles
• Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism  Journal Articles
• Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography  Journal Articles
• Routine measurement of DOAC concentrations for prognostication and clinical management in acute ischemic stroke: Is it ready for prime time?  Journal Articles
• Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis  Journal Articles
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia  Journal Articles
• Severe thrombophilia in a factor V‐deficient patient homozygous for the Ala2086Asp mutation (FV Besançon)  Journal Articles
• Shortening of the Bleeding Time in Rabbits by Hydrocortisone Caused by Inhibition of Prostacyclin Generation by the Vessel Wall  Journal Articles
• Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis  Journal Articles
• Streptokinase in acute major pulmonary embolism.  Journal Articles
• Studies on East African Snakes  Journal Articles
• Studies on the coagulant enzyme from Agkistrodon rhodostoma venom. Isolation and some properties of the enzyme  Journal Articles
• Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial  Journal Articles
• TREATMENT OF VENOUS THROMBOEMBOLISM  Journal Articles
• The Activated Partial Thromboplastin Time in the Control of Heparin Treatment  Journal Articles
• The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy  Journal Articles
• The Influence of Age on in vitro Plasmin Generation in the Presence of Fibrin Monomer  Journal Articles
• The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study  Journal Articles
• The Value of Plasma Calibrants in Correcting Coagulometer Effects on International Normalized Ratios:An International Multicenter Study  Journal Articles
• The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.  Journal Articles
• The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of α1-proteinase inhibitor M358R for thrombin  Journal Articles
• The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig  Journal Articles
• The direct thrombin inhibitor hirudin  Journal Articles
• The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization.  Journal Articles
• The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro  Journal Articles
• The influence of drugs upon the anticoagulant activity of heparin.  Journal Articles
• The influence of heparin, NaCl and CaCl2 on the rate of the thrombin-antithrombin III reaction  Journal Articles
• The multiple faces of the partial thromboplastin time APTT  Journal Articles
• The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin  Journal Articles
• The unique characteristics of COVID-19 coagulopathy  Journal Articles
• The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease.  Journal Articles
• Theoretical and Practical Aspects of Thrombolytic Therapy  Journal Articles
• Thrombin Generation  Journal Articles
• Thrombin activation rate constant: One-stage chromogenic assay for the extrinsic system  Journal Articles
• Thrombin generation abnormalities in commonly encountered platelet function disorders  Journal Articles
• Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.  Journal Articles
• Thrombin/Antithrombin III Complex Formation in the Neonatal Respiratory Distress Syndrome  Journal Articles
• Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis  Journal Articles
• Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin  Journal Articles
• Thrombus stability explains the factor V Leiden paradox: a mouse model  Journal Articles
• Transfusion-Induced Specific Anti–Factor XI Inhibitor in a Patient with Previously Unrecognized Factor XI Deficiency  Journal Articles
• Treatment of Venous Thromboembolism  Journal Articles
• Treatment of venous thromboembolic disease.  Journal Articles
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Journal Articles
• Urgent Need to Measure Effects of Direct Oral Anticoagulants  Journal Articles
• VON WILLEBRAND'S DISEASE  Journal Articles
• Validation of the time to attain maximal clot amplitude after reaching maximal clot formation velocity parameter as a measure of fibrinolysis using rotational thromboelastometry and its application in the assessment of fibrinolytic resistance in septic patients: a prospective observational study: communication from the ISTH SSC Subcommittee on Fibrinolysis  Journal Articles
• Vasoflux, a New Anticoagulant With a Novel Mechanism of Action  Journal Articles
• Von Willebrand's Syndrome Presenting as an Acquired Bleeding Disorder in Association With a Monoclonal Gammopathy  Journal Articles
• [Population pharmacokinetics of two recombinant human coagulation factor Ⅷ preparations in patients with hemophilia A].  Journal Articles
• von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis  Journal Articles